Global Transforming Growth Factor Beta 1 Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Transforming Growth Factor Beta 1 market size is predicted to grow from US$ 1758 million in 2025 to US$ 3381 million in 2031; it is expected to grow at a CAGR of 11.5% from 2025 to 2031.
Transforming growth factor beta 1 or TGF-?1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-?1 is encoded by the TGFB1 gene
North America is the largest Transforming Growth Factor Beta 1 market with about 69% market share. Europe is follower, accounting for about 16% market share.The key manufacturers are Roche, Shionogi Ltd, Acceleron Pharma Inc, Genzyme Corp, Isarna Therapeutics GmbH, Scholar Rock, Sirnaomics Inc, Eli Lilly and Co, Formation Biologics Inc, Novartis AG etc.
LP Information, Inc. (LPI) ' newest research report, the “Transforming Growth Factor Beta 1 Industry Forecast” looks at past sales and reviews total world Transforming Growth Factor Beta 1 sales in 2024, providing a comprehensive analysis by region and market sector of projected Transforming Growth Factor Beta 1 sales for 2025 through 2031. With Transforming Growth Factor Beta 1 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transforming Growth Factor Beta 1 industry.
This Insight Report provides a comprehensive analysis of the global Transforming Growth Factor Beta 1 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Transforming Growth Factor Beta 1 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Transforming Growth Factor Beta 1 market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transforming Growth Factor Beta 1 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transforming Growth Factor Beta 1.
This report presents a comprehensive overview, market shares, and growth opportunities of Transforming Growth Factor Beta 1 market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Transforming Growth Factor Beta 1 market?
What factors are driving Transforming Growth Factor Beta 1 market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Transforming Growth Factor Beta 1 market opportunities vary by end market size?
How does Transforming Growth Factor Beta 1 break out by Type, by Application?
The global Transforming Growth Factor Beta 1 market size is predicted to grow from US$ 1758 million in 2025 to US$ 3381 million in 2031; it is expected to grow at a CAGR of 11.5% from 2025 to 2031.
Transforming growth factor beta 1 or TGF-?1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-?1 is encoded by the TGFB1 gene
North America is the largest Transforming Growth Factor Beta 1 market with about 69% market share. Europe is follower, accounting for about 16% market share.The key manufacturers are Roche, Shionogi Ltd, Acceleron Pharma Inc, Genzyme Corp, Isarna Therapeutics GmbH, Scholar Rock, Sirnaomics Inc, Eli Lilly and Co, Formation Biologics Inc, Novartis AG etc.
LP Information, Inc. (LPI) ' newest research report, the “Transforming Growth Factor Beta 1 Industry Forecast” looks at past sales and reviews total world Transforming Growth Factor Beta 1 sales in 2024, providing a comprehensive analysis by region and market sector of projected Transforming Growth Factor Beta 1 sales for 2025 through 2031. With Transforming Growth Factor Beta 1 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transforming Growth Factor Beta 1 industry.
This Insight Report provides a comprehensive analysis of the global Transforming Growth Factor Beta 1 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Transforming Growth Factor Beta 1 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Transforming Growth Factor Beta 1 market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transforming Growth Factor Beta 1 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transforming Growth Factor Beta 1.
This report presents a comprehensive overview, market shares, and growth opportunities of Transforming Growth Factor Beta 1 market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Pirfenidone
- Galunisertib
- Others
- IPF
- Cancer
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Shionogi Ltd
- Acceleron Pharma Inc
- Genzyme Corp
- Isarna Therapeutics GmbH
- Scholar Rock
- Sirnaomics Inc
- Eli Lilly and Co
- Formation Biologics Inc
- Novartis AG
What is the 10-year outlook for the global Transforming Growth Factor Beta 1 market?
What factors are driving Transforming Growth Factor Beta 1 market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Transforming Growth Factor Beta 1 market opportunities vary by end market size?
How does Transforming Growth Factor Beta 1 break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Transforming Growth Factor Beta 1 Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Transforming Growth Factor Beta 1 by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Transforming Growth Factor Beta 1 by Country/Region, 2020, 2024 & 2031
2.2 Transforming Growth Factor Beta 1 Segment by Type
2.2.1 Pirfenidone
2.2.2 Galunisertib
2.2.3 Others
2.3 Transforming Growth Factor Beta 1 Sales by Type
2.3.1 Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2020-2025)
2.3.2 Global Transforming Growth Factor Beta 1 Revenue and Market Share by Type (2020-2025)
2.3.3 Global Transforming Growth Factor Beta 1 Sale Price by Type (2020-2025)
2.4 Transforming Growth Factor Beta 1 Segment by Application
2.4.1 IPF
2.4.2 Cancer
2.4.3 Others
2.5 Transforming Growth Factor Beta 1 Sales by Application
2.5.1 Global Transforming Growth Factor Beta 1 Sale Market Share by Application (2020-2025)
2.5.2 Global Transforming Growth Factor Beta 1 Revenue and Market Share by Application (2020-2025)
2.5.3 Global Transforming Growth Factor Beta 1 Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Transforming Growth Factor Beta 1 Breakdown Data by Company
3.1.1 Global Transforming Growth Factor Beta 1 Annual Sales by Company (2020-2025)
3.1.2 Global Transforming Growth Factor Beta 1 Sales Market Share by Company (2020-2025)
3.2 Global Transforming Growth Factor Beta 1 Annual Revenue by Company (2020-2025)
3.2.1 Global Transforming Growth Factor Beta 1 Revenue by Company (2020-2025)
3.2.2 Global Transforming Growth Factor Beta 1 Revenue Market Share by Company (2020-2025)
3.3 Global Transforming Growth Factor Beta 1 Sale Price by Company
3.4 Key Manufacturers Transforming Growth Factor Beta 1 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Transforming Growth Factor Beta 1 Product Location Distribution
3.4.2 Players Transforming Growth Factor Beta 1 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TRANSFORMING GROWTH FACTOR BETA 1 BY GEOGRAPHIC REGION
4.1 World Historic Transforming Growth Factor Beta 1 Market Size by Geographic Region (2020-2025)
4.1.1 Global Transforming Growth Factor Beta 1 Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Transforming Growth Factor Beta 1 Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Transforming Growth Factor Beta 1 Market Size by Country/Region (2020-2025)
4.2.1 Global Transforming Growth Factor Beta 1 Annual Sales by Country/Region (2020-2025)
4.2.2 Global Transforming Growth Factor Beta 1 Annual Revenue by Country/Region (2020-2025)
4.3 Americas Transforming Growth Factor Beta 1 Sales Growth
4.4 APAC Transforming Growth Factor Beta 1 Sales Growth
4.5 Europe Transforming Growth Factor Beta 1 Sales Growth
4.6 Middle East & Africa Transforming Growth Factor Beta 1 Sales Growth
5 AMERICAS
5.1 Americas Transforming Growth Factor Beta 1 Sales by Country
5.1.1 Americas Transforming Growth Factor Beta 1 Sales by Country (2020-2025)
5.1.2 Americas Transforming Growth Factor Beta 1 Revenue by Country (2020-2025)
5.2 Americas Transforming Growth Factor Beta 1 Sales by Type (2020-2025)
5.3 Americas Transforming Growth Factor Beta 1 Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transforming Growth Factor Beta 1 Sales by Region
6.1.1 APAC Transforming Growth Factor Beta 1 Sales by Region (2020-2025)
6.1.2 APAC Transforming Growth Factor Beta 1 Revenue by Region (2020-2025)
6.2 APAC Transforming Growth Factor Beta 1 Sales by Type (2020-2025)
6.3 APAC Transforming Growth Factor Beta 1 Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Transforming Growth Factor Beta 1 by Country
7.1.1 Europe Transforming Growth Factor Beta 1 Sales by Country (2020-2025)
7.1.2 Europe Transforming Growth Factor Beta 1 Revenue by Country (2020-2025)
7.2 Europe Transforming Growth Factor Beta 1 Sales by Type (2020-2025)
7.3 Europe Transforming Growth Factor Beta 1 Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Transforming Growth Factor Beta 1 by Country
8.1.1 Middle East & Africa Transforming Growth Factor Beta 1 Sales by Country (2020-2025)
8.1.2 Middle East & Africa Transforming Growth Factor Beta 1 Revenue by Country (2020-2025)
8.2 Middle East & Africa Transforming Growth Factor Beta 1 Sales by Type (2020-2025)
8.3 Middle East & Africa Transforming Growth Factor Beta 1 Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Transforming Growth Factor Beta
10.3 Manufacturing Process Analysis of Transforming Growth Factor Beta
10.4 Industry Chain Structure of Transforming Growth Factor Beta
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Transforming Growth Factor Beta 1 Distributors
11.3 Transforming Growth Factor Beta 1 Customer
12 WORLD FORECAST REVIEW FOR TRANSFORMING GROWTH FACTOR BETA 1 BY GEOGRAPHIC REGION
12.1 Global Transforming Growth Factor Beta 1 Market Size Forecast by Region
12.1.1 Global Transforming Growth Factor Beta 1 Forecast by Region (2026-2031)
12.1.2 Global Transforming Growth Factor Beta 1 Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Transforming Growth Factor Beta 1 Forecast by Type (2026-2031)
12.7 Global Transforming Growth Factor Beta 1 Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.1.3 Roche Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Shionogi Ltd
13.2.1 Shionogi Ltd Company Information
13.2.2 Shionogi Ltd Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Shionogi Ltd Main Business Overview
13.2.5 Shionogi Ltd Latest Developments
13.3 Acceleron Pharma Inc
13.3.1 Acceleron Pharma Inc Company Information
13.3.2 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Acceleron Pharma Inc Main Business Overview
13.3.5 Acceleron Pharma Inc Latest Developments
13.4 Genzyme Corp
13.4.1 Genzyme Corp Company Information
13.4.2 Genzyme Corp Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Genzyme Corp Main Business Overview
13.4.5 Genzyme Corp Latest Developments
13.5 Isarna Therapeutics GmbH
13.5.1 Isarna Therapeutics GmbH Company Information
13.5.2 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Isarna Therapeutics GmbH Main Business Overview
13.5.5 Isarna Therapeutics GmbH Latest Developments
13.6 Scholar Rock
13.6.1 Scholar Rock Company Information
13.6.2 Scholar Rock Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.6.3 Scholar Rock Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Scholar Rock Main Business Overview
13.6.5 Scholar Rock Latest Developments
13.7 Sirnaomics Inc
13.7.1 Sirnaomics Inc Company Information
13.7.2 Sirnaomics Inc Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.7.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Sirnaomics Inc Main Business Overview
13.7.5 Sirnaomics Inc Latest Developments
13.8 Eli Lilly and Co
13.8.1 Eli Lilly and Co Company Information
13.8.2 Eli Lilly and Co Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Eli Lilly and Co Main Business Overview
13.8.5 Eli Lilly and Co Latest Developments
13.9 Formation Biologics Inc
13.9.1 Formation Biologics Inc Company Information
13.9.2 Formation Biologics Inc Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Formation Biologics Inc Main Business Overview
13.9.5 Formation Biologics Inc Latest Developments
13.10 Novartis AG
13.10.1 Novartis AG Company Information
13.10.2 Novartis AG Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.10.3 Novartis AG Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Novartis AG Main Business Overview
13.10.5 Novartis AG Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1.Transforming GrowthFactor Beta 1 Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2.Transforming GrowthFactor Beta 1 Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Pirfenidone
Table 4. Major Players of Galunisertib
Table 5. Major Players of Others
Table 6. GlobalTransforming GrowthFactor Beta 1 Sales byType (2020-2025) & (K Units)
Table 7. GlobalTransforming GrowthFactor Beta 1 Sales Market Share byType (2020-2025)
Table 8. GlobalTransforming GrowthFactor Beta 1 Revenue byType (2020-2025) & ($ million)
Table 9. GlobalTransforming GrowthFactor Beta 1 Revenue Market Share byType (2020-2025)
Table 10. GlobalTransforming GrowthFactor Beta 1 Sale Price byType (2020-2025) & (USD/Unit)
Table 11. GlobalTransforming GrowthFactor Beta 1 Sale by Application (2020-2025) & (K Units)
Table 12. GlobalTransforming GrowthFactor Beta 1 Sale Market Share by Application (2020-2025)
Table 13. GlobalTransforming GrowthFactor Beta 1 Revenue by Application (2020-2025) & ($ million)
Table 14. GlobalTransforming GrowthFactor Beta 1 Revenue Market Share by Application (2020-2025)
Table 15. GlobalTransforming GrowthFactor Beta 1 Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. GlobalTransforming GrowthFactor Beta 1 Sales by Company (2020-2025) & (K Units)
Table 17. GlobalTransforming GrowthFactor Beta 1 Sales Market Share by Company (2020-2025)
Table 18. GlobalTransforming GrowthFactor Beta 1 Revenue by Company (2020-2025) & ($ millions)
Table 19. GlobalTransforming GrowthFactor Beta 1 Revenue Market Share by Company (2020-2025)
Table 20. GlobalTransforming GrowthFactor Beta 1 Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key ManufacturersTransforming GrowthFactor Beta 1 Producing Area Distribution and Sales Area
Table 22. PlayersTransforming GrowthFactor Beta 1 Products Offered
Table 23.Transforming GrowthFactor Beta 1 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. GlobalTransforming GrowthFactor Beta 1 Sales by Geographic Region (2020-2025) & (K Units)
Table 27. GlobalTransforming GrowthFactor Beta 1 Sales Market Share Geographic Region (2020-2025)
Table 28. GlobalTransforming GrowthFactor Beta 1 Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. GlobalTransforming GrowthFactor Beta 1 Revenue Market Share by Geographic Region (2020-2025)
Table 30. GlobalTransforming GrowthFactor Beta 1 Sales by Country/Region (2020-2025) & (K Units)
Table 31. GlobalTransforming GrowthFactor Beta 1 Sales Market Share by Country/Region (2020-2025)
Table 32. GlobalTransforming GrowthFactor Beta 1 Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. GlobalTransforming GrowthFactor Beta 1 Revenue Market Share by Country/Region (2020-2025)
Table 34. AmericasTransforming GrowthFactor Beta 1 Sales by Country (2020-2025) & (K Units)
Table 35. AmericasTransforming GrowthFactor Beta 1 Sales Market Share by Country (2020-2025)
Table 36. AmericasTransforming GrowthFactor Beta 1 Revenue by Country (2020-2025) & ($ millions)
Table 37. AmericasTransforming GrowthFactor Beta 1 Sales byType (2020-2025) & (K Units)
Table 38. AmericasTransforming GrowthFactor Beta 1 Sales by Application (2020-2025) & (K Units)
Table 39. APACTransforming GrowthFactor Beta 1 Sales by Region (2020-2025) & (K Units)
Table 40. APACTransforming GrowthFactor Beta 1 Sales Market Share by Region (2020-2025)
Table 41. APACTransforming GrowthFactor Beta 1 Revenue by Region (2020-2025) & ($ millions)
Table 42. APACTransforming GrowthFactor Beta 1 Sales byType (2020-2025) & (K Units)
Table 43. APACTransforming GrowthFactor Beta 1 Sales by Application (2020-2025) & (K Units)
Table 44. EuropeTransforming GrowthFactor Beta 1 Sales by Country (2020-2025) & (K Units)
Table 45. EuropeTransforming GrowthFactor Beta 1 Revenue by Country (2020-2025) & ($ millions)
Table 46. EuropeTransforming GrowthFactor Beta 1 Sales byType (2020-2025) & (K Units)
Table 47. EuropeTransforming GrowthFactor Beta 1 Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & AfricaTransforming GrowthFactor Beta 1 Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & AfricaTransforming GrowthFactor Beta 1 Revenue Market Share by Country (2020-2025)
Table 50. Middle East & AfricaTransforming GrowthFactor Beta 1 Sales byType (2020-2025) & (K Units)
Table 51. Middle East & AfricaTransforming GrowthFactor Beta 1 Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities ofTransforming GrowthFactor Beta 1
Table 53. Key Market Challenges & Risks ofTransforming GrowthFactor Beta 1
Table 54. Key IndustryTrends ofTransforming GrowthFactor Beta 1
Table 55.Transforming GrowthFactor Beta 1 Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57.Transforming GrowthFactor Beta 1 Distributors List
Table 58.Transforming GrowthFactor Beta 1 Customer List
Table 59. GlobalTransforming GrowthFactor Beta 1 SalesForecast by Region (2026-2031) & (K Units)
Table 60. GlobalTransforming GrowthFactor Beta 1 RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. AmericasTransforming GrowthFactor Beta 1 SalesForecast by Country (2026-2031) & (K Units)
Table 62. AmericasTransforming GrowthFactor Beta 1 Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APACTransforming GrowthFactor Beta 1 SalesForecast by Region (2026-2031) & (K Units)
Table 64. APACTransforming GrowthFactor Beta 1 Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. EuropeTransforming GrowthFactor Beta 1 SalesForecast by Country (2026-2031) & (K Units)
Table 66. EuropeTransforming GrowthFactor Beta 1 RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & AfricaTransforming GrowthFactor Beta 1 SalesForecast by Country (2026-2031) & (K Units)
Table 68. Middle East & AfricaTransforming GrowthFactor Beta 1 RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. GlobalTransforming GrowthFactor Beta 1 SalesForecast byType (2026-2031) & (K Units)
Table 70. GlobalTransforming GrowthFactor Beta 1 RevenueForecast byType (2026-2031) & ($ millions)
Table 71. GlobalTransforming GrowthFactor Beta 1 SalesForecast by Application (2026-2031) & (K Units)
Table 72. GlobalTransforming GrowthFactor Beta 1 RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Roche Basic Information,Transforming GrowthFactor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 74. RocheTransforming GrowthFactor Beta 1 Product Portfolios and Specifications
Table 75. RocheTransforming GrowthFactor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Roche Main Business
Table 77. Roche Latest Developments
Table 78. Shionogi Ltd Basic Information,Transforming GrowthFactor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 79. Shionogi LtdTransforming GrowthFactor Beta 1 Product Portfolios and Specifications
Table 80. Shionogi LtdTransforming GrowthFactor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Shionogi Ltd Main Business
Table 82. Shionogi Ltd Latest Developments
Table 83. Acceleron Pharma Inc Basic Information,Transforming GrowthFactor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 84. Acceleron Pharma IncTransforming GrowthFactor Beta 1 Product Portfolios and Specifications
Table 85. Acceleron Pharma IncTransforming GrowthFactor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Acceleron Pharma Inc Main Business
Table 87. Acceleron Pharma Inc Latest Developments
Table 88. Genzyme Corp Basic Information,Transforming GrowthFactor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 89. Genzyme CorpTransforming GrowthFactor Beta 1 Product Portfolios and Specifications
Table 90. Genzyme CorpTransforming GrowthFactor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Genzyme Corp Main Business
Table 92. Genzyme Corp Latest Developments
Table 93. IsarnaTherapeutics GmbH Basic Information,Transforming GrowthFactor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 94. IsarnaTherapeutics GmbHTransforming GrowthFactor Beta 1 Product Portfolios and Specifications
Table 95. IsarnaTherapeutics GmbHTransforming GrowthFactor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. IsarnaTherapeutics GmbH Main Business
Table 97. IsarnaTherapeutics GmbH Latest Developments
Table 98. Scholar Rock Basic Information,Transforming GrowthFactor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 99. Scholar RockTransforming GrowthFactor Beta 1 Product Portfolios and Specifications
Table 100. Scholar RockTransforming GrowthFactor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Scholar Rock Main Business
Table 102. Scholar Rock Latest Developments
Table 103. Sirnaomics Inc Basic Information,Transforming GrowthFactor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 104. Sirnaomics IncTransforming GrowthFactor Beta 1 Product Portfolios and Specifications
Table 105. Sirnaomics IncTransforming GrowthFactor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Sirnaomics Inc Main Business
Table 107. Sirnaomics Inc Latest Developments
Table 108. Eli Lilly and Co Basic Information,Transforming GrowthFactor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 109. Eli Lilly and CoTransforming GrowthFactor Beta 1 Product Portfolios and Specifications
Table 110. Eli Lilly and CoTransforming GrowthFactor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Eli Lilly and Co Main Business
Table 112. Eli Lilly and Co Latest Developments
Table 113.Formation Biologics Inc Basic Information,Transforming GrowthFactor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 114.Formation Biologics IncTransforming GrowthFactor Beta 1 Product Portfolios and Specifications
Table 115.Formation Biologics IncTransforming GrowthFactor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116.Formation Biologics Inc Main Business
Table 117.Formation Biologics Inc Latest Developments
Table 118. Novartis AG Basic Information,Transforming GrowthFactor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 119. Novartis AGTransforming GrowthFactor Beta 1 Product Portfolios and Specifications
Table 120. Novartis AGTransforming GrowthFactor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Novartis AG Main Business
Table 122. Novartis AG Latest Developments
LIST OFFIGURES
Figure 1. Picture ofTransforming GrowthFactor Beta 1
Figure 2.Transforming GrowthFactor Beta 1 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. GlobalTransforming GrowthFactor Beta 1 Sales Growth Rate 2020-2031 (K Units)
Figure 7. GlobalTransforming GrowthFactor Beta 1 Revenue Growth Rate 2020-2031 ($ millions)
Figure 8.Transforming GrowthFactor Beta 1 Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9.Transforming GrowthFactor Beta 1 Sales Market Share by Country/Region (2024)
Figure 10.Transforming GrowthFactor Beta 1 Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Pirfenidone
Figure 12. Product Picture of Galunisertib
Figure 13. Product Picture of Others
Figure 14. GlobalTransforming GrowthFactor Beta 1 Sales Market Share byType in 2025
Figure 15. GlobalTransforming GrowthFactor Beta 1 Revenue Market Share byType (2020-2025)
Figure 16.Transforming GrowthFactor Beta 1 Consumed in IPF
Figure 17. GlobalTransforming GrowthFactor Beta 1 Market: IPF (2020-2025) & (K Units)
Figure 18.Transforming GrowthFactor Beta 1 Consumed in Cancer
Figure 19. GlobalTransforming GrowthFactor Beta 1 Market: Cancer (2020-2025) & (K Units)
Figure 20.Transforming GrowthFactor Beta 1 Consumed in Others
Figure 21. GlobalTransforming GrowthFactor Beta 1 Market: Others (2020-2025) & (K Units)
Figure 22. GlobalTransforming GrowthFactor Beta 1 Sale Market Share by Application (2024)
Figure 23. GlobalTransforming GrowthFactor Beta 1 Revenue Market Share by Application in 2025
Figure 24.Transforming GrowthFactor Beta 1 Sales by Company in 2025 (K Units)
Figure 25. GlobalTransforming GrowthFactor Beta 1 Sales Market Share by Company in 2025
Figure 26.Transforming GrowthFactor Beta 1 Revenue by Company in 2025 ($ millions)
Figure 27. GlobalTransforming GrowthFactor Beta 1 Revenue Market Share by Company in 2025
Figure 28. GlobalTransforming GrowthFactor Beta 1 Sales Market Share by Geographic Region (2020-2025)
Figure 29. GlobalTransforming GrowthFactor Beta 1 Revenue Market Share by Geographic Region in 2025
Figure 30. AmericasTransforming GrowthFactor Beta 1 Sales 2020-2025 (K Units)
Figure 31. AmericasTransforming GrowthFactor Beta 1 Revenue 2020-2025 ($ millions)
Figure 32. APACTransforming GrowthFactor Beta 1 Sales 2020-2025 (K Units)
Figure 33. APACTransforming GrowthFactor Beta 1 Revenue 2020-2025 ($ millions)
Figure 34. EuropeTransforming GrowthFactor Beta 1 Sales 2020-2025 (K Units)
Figure 35. EuropeTransforming GrowthFactor Beta 1 Revenue 2020-2025 ($ millions)
Figure 36. Middle East & AfricaTransforming GrowthFactor Beta 1 Sales 2020-2025 (K Units)
Figure 37. Middle East & AfricaTransforming GrowthFactor Beta 1 Revenue 2020-2025 ($ millions)
Figure 38. AmericasTransforming GrowthFactor Beta 1 Sales Market Share by Country in 2025
Figure 39. AmericasTransforming GrowthFactor Beta 1 Revenue Market Share by Country (2020-2025)
Figure 40. AmericasTransforming GrowthFactor Beta 1 Sales Market Share byType (2020-2025)
Figure 41. AmericasTransforming GrowthFactor Beta 1 Sales Market Share by Application (2020-2025)
Figure 42. United StatesTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 43. CanadaTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 44. MexicoTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 45. BrazilTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 46. APACTransforming GrowthFactor Beta 1 Sales Market Share by Region in 2025
Figure 47. APACTransforming GrowthFactor Beta 1 Revenue Market Share by Region (2020-2025)
Figure 48. APACTransforming GrowthFactor Beta 1 Sales Market Share byType (2020-2025)
Figure 49. APACTransforming GrowthFactor Beta 1 Sales Market Share by Application (2020-2025)
Figure 50. ChinaTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 51. JapanTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 52. South KoreaTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast AsiaTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 54. IndiaTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 55. AustraliaTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwanTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 57. EuropeTransforming GrowthFactor Beta 1 Sales Market Share by Country in 2025
Figure 58. EuropeTransforming GrowthFactor Beta 1 Revenue Market Share by Country (2020-2025)
Figure 59. EuropeTransforming GrowthFactor Beta 1 Sales Market Share byType (2020-2025)
Figure 60. EuropeTransforming GrowthFactor Beta 1 Sales Market Share by Application (2020-2025)
Figure 61. GermanyTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 62.FranceTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 63. UKTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 64. ItalyTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 65. RussiaTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & AfricaTransforming GrowthFactor Beta 1 Sales Market Share by Country (2020-2025)
Figure 67. Middle East & AfricaTransforming GrowthFactor Beta 1 Sales Market Share byType (2020-2025)
Figure 68. Middle East & AfricaTransforming GrowthFactor Beta 1 Sales Market Share by Application (2020-2025)
Figure 69. EgyptTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 70. South AfricaTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 71. IsraelTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 72.TurkeyTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC CountriesTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis ofTransforming GrowthFactor Beta 1 in 2025
Figure 75. Manufacturing Process Analysis ofTransforming GrowthFactor Beta 1
Figure 76. Industry Chain Structure ofTransforming GrowthFactor Beta 1
Figure 77. Channels of Distribution
Figure 78. GlobalTransforming GrowthFactor Beta 1 Sales MarketForecast by Region (2026-2031)
Figure 79. GlobalTransforming GrowthFactor Beta 1 Revenue Market ShareForecast by Region (2026-2031)
Figure 80. GlobalTransforming GrowthFactor Beta 1 Sales Market ShareForecast byType (2026-2031)
Figure 81. GlobalTransforming GrowthFactor Beta 1 Revenue Market ShareForecast byType (2026-2031)
Figure 82. GlobalTransforming GrowthFactor Beta 1 Sales Market ShareForecast by Application (2026-2031)
Figure 83. GlobalTransforming GrowthFactor Beta 1 Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Transforming Growth Factor Beta 1 Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Transforming Growth Factor Beta 1 by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Transforming Growth Factor Beta 1 by Country/Region, 2020, 2024 & 2031
2.2 Transforming Growth Factor Beta 1 Segment by Type
2.2.1 Pirfenidone
2.2.2 Galunisertib
2.2.3 Others
2.3 Transforming Growth Factor Beta 1 Sales by Type
2.3.1 Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2020-2025)
2.3.2 Global Transforming Growth Factor Beta 1 Revenue and Market Share by Type (2020-2025)
2.3.3 Global Transforming Growth Factor Beta 1 Sale Price by Type (2020-2025)
2.4 Transforming Growth Factor Beta 1 Segment by Application
2.4.1 IPF
2.4.2 Cancer
2.4.3 Others
2.5 Transforming Growth Factor Beta 1 Sales by Application
2.5.1 Global Transforming Growth Factor Beta 1 Sale Market Share by Application (2020-2025)
2.5.2 Global Transforming Growth Factor Beta 1 Revenue and Market Share by Application (2020-2025)
2.5.3 Global Transforming Growth Factor Beta 1 Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Transforming Growth Factor Beta 1 Breakdown Data by Company
3.1.1 Global Transforming Growth Factor Beta 1 Annual Sales by Company (2020-2025)
3.1.2 Global Transforming Growth Factor Beta 1 Sales Market Share by Company (2020-2025)
3.2 Global Transforming Growth Factor Beta 1 Annual Revenue by Company (2020-2025)
3.2.1 Global Transforming Growth Factor Beta 1 Revenue by Company (2020-2025)
3.2.2 Global Transforming Growth Factor Beta 1 Revenue Market Share by Company (2020-2025)
3.3 Global Transforming Growth Factor Beta 1 Sale Price by Company
3.4 Key Manufacturers Transforming Growth Factor Beta 1 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Transforming Growth Factor Beta 1 Product Location Distribution
3.4.2 Players Transforming Growth Factor Beta 1 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TRANSFORMING GROWTH FACTOR BETA 1 BY GEOGRAPHIC REGION
4.1 World Historic Transforming Growth Factor Beta 1 Market Size by Geographic Region (2020-2025)
4.1.1 Global Transforming Growth Factor Beta 1 Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Transforming Growth Factor Beta 1 Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Transforming Growth Factor Beta 1 Market Size by Country/Region (2020-2025)
4.2.1 Global Transforming Growth Factor Beta 1 Annual Sales by Country/Region (2020-2025)
4.2.2 Global Transforming Growth Factor Beta 1 Annual Revenue by Country/Region (2020-2025)
4.3 Americas Transforming Growth Factor Beta 1 Sales Growth
4.4 APAC Transforming Growth Factor Beta 1 Sales Growth
4.5 Europe Transforming Growth Factor Beta 1 Sales Growth
4.6 Middle East & Africa Transforming Growth Factor Beta 1 Sales Growth
5 AMERICAS
5.1 Americas Transforming Growth Factor Beta 1 Sales by Country
5.1.1 Americas Transforming Growth Factor Beta 1 Sales by Country (2020-2025)
5.1.2 Americas Transforming Growth Factor Beta 1 Revenue by Country (2020-2025)
5.2 Americas Transforming Growth Factor Beta 1 Sales by Type (2020-2025)
5.3 Americas Transforming Growth Factor Beta 1 Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transforming Growth Factor Beta 1 Sales by Region
6.1.1 APAC Transforming Growth Factor Beta 1 Sales by Region (2020-2025)
6.1.2 APAC Transforming Growth Factor Beta 1 Revenue by Region (2020-2025)
6.2 APAC Transforming Growth Factor Beta 1 Sales by Type (2020-2025)
6.3 APAC Transforming Growth Factor Beta 1 Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Transforming Growth Factor Beta 1 by Country
7.1.1 Europe Transforming Growth Factor Beta 1 Sales by Country (2020-2025)
7.1.2 Europe Transforming Growth Factor Beta 1 Revenue by Country (2020-2025)
7.2 Europe Transforming Growth Factor Beta 1 Sales by Type (2020-2025)
7.3 Europe Transforming Growth Factor Beta 1 Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Transforming Growth Factor Beta 1 by Country
8.1.1 Middle East & Africa Transforming Growth Factor Beta 1 Sales by Country (2020-2025)
8.1.2 Middle East & Africa Transforming Growth Factor Beta 1 Revenue by Country (2020-2025)
8.2 Middle East & Africa Transforming Growth Factor Beta 1 Sales by Type (2020-2025)
8.3 Middle East & Africa Transforming Growth Factor Beta 1 Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Transforming Growth Factor Beta
10.3 Manufacturing Process Analysis of Transforming Growth Factor Beta
10.4 Industry Chain Structure of Transforming Growth Factor Beta
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Transforming Growth Factor Beta 1 Distributors
11.3 Transforming Growth Factor Beta 1 Customer
12 WORLD FORECAST REVIEW FOR TRANSFORMING GROWTH FACTOR BETA 1 BY GEOGRAPHIC REGION
12.1 Global Transforming Growth Factor Beta 1 Market Size Forecast by Region
12.1.1 Global Transforming Growth Factor Beta 1 Forecast by Region (2026-2031)
12.1.2 Global Transforming Growth Factor Beta 1 Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Transforming Growth Factor Beta 1 Forecast by Type (2026-2031)
12.7 Global Transforming Growth Factor Beta 1 Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.1.3 Roche Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Shionogi Ltd
13.2.1 Shionogi Ltd Company Information
13.2.2 Shionogi Ltd Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Shionogi Ltd Main Business Overview
13.2.5 Shionogi Ltd Latest Developments
13.3 Acceleron Pharma Inc
13.3.1 Acceleron Pharma Inc Company Information
13.3.2 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Acceleron Pharma Inc Main Business Overview
13.3.5 Acceleron Pharma Inc Latest Developments
13.4 Genzyme Corp
13.4.1 Genzyme Corp Company Information
13.4.2 Genzyme Corp Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Genzyme Corp Main Business Overview
13.4.5 Genzyme Corp Latest Developments
13.5 Isarna Therapeutics GmbH
13.5.1 Isarna Therapeutics GmbH Company Information
13.5.2 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Isarna Therapeutics GmbH Main Business Overview
13.5.5 Isarna Therapeutics GmbH Latest Developments
13.6 Scholar Rock
13.6.1 Scholar Rock Company Information
13.6.2 Scholar Rock Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.6.3 Scholar Rock Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Scholar Rock Main Business Overview
13.6.5 Scholar Rock Latest Developments
13.7 Sirnaomics Inc
13.7.1 Sirnaomics Inc Company Information
13.7.2 Sirnaomics Inc Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.7.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Sirnaomics Inc Main Business Overview
13.7.5 Sirnaomics Inc Latest Developments
13.8 Eli Lilly and Co
13.8.1 Eli Lilly and Co Company Information
13.8.2 Eli Lilly and Co Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Eli Lilly and Co Main Business Overview
13.8.5 Eli Lilly and Co Latest Developments
13.9 Formation Biologics Inc
13.9.1 Formation Biologics Inc Company Information
13.9.2 Formation Biologics Inc Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Formation Biologics Inc Main Business Overview
13.9.5 Formation Biologics Inc Latest Developments
13.10 Novartis AG
13.10.1 Novartis AG Company Information
13.10.2 Novartis AG Transforming Growth Factor Beta 1 Product Portfolios and Specifications
13.10.3 Novartis AG Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Novartis AG Main Business Overview
13.10.5 Novartis AG Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1.Transforming GrowthFactor Beta 1 Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2.Transforming GrowthFactor Beta 1 Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Pirfenidone
Table 4. Major Players of Galunisertib
Table 5. Major Players of Others
Table 6. GlobalTransforming GrowthFactor Beta 1 Sales byType (2020-2025) & (K Units)
Table 7. GlobalTransforming GrowthFactor Beta 1 Sales Market Share byType (2020-2025)
Table 8. GlobalTransforming GrowthFactor Beta 1 Revenue byType (2020-2025) & ($ million)
Table 9. GlobalTransforming GrowthFactor Beta 1 Revenue Market Share byType (2020-2025)
Table 10. GlobalTransforming GrowthFactor Beta 1 Sale Price byType (2020-2025) & (USD/Unit)
Table 11. GlobalTransforming GrowthFactor Beta 1 Sale by Application (2020-2025) & (K Units)
Table 12. GlobalTransforming GrowthFactor Beta 1 Sale Market Share by Application (2020-2025)
Table 13. GlobalTransforming GrowthFactor Beta 1 Revenue by Application (2020-2025) & ($ million)
Table 14. GlobalTransforming GrowthFactor Beta 1 Revenue Market Share by Application (2020-2025)
Table 15. GlobalTransforming GrowthFactor Beta 1 Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. GlobalTransforming GrowthFactor Beta 1 Sales by Company (2020-2025) & (K Units)
Table 17. GlobalTransforming GrowthFactor Beta 1 Sales Market Share by Company (2020-2025)
Table 18. GlobalTransforming GrowthFactor Beta 1 Revenue by Company (2020-2025) & ($ millions)
Table 19. GlobalTransforming GrowthFactor Beta 1 Revenue Market Share by Company (2020-2025)
Table 20. GlobalTransforming GrowthFactor Beta 1 Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key ManufacturersTransforming GrowthFactor Beta 1 Producing Area Distribution and Sales Area
Table 22. PlayersTransforming GrowthFactor Beta 1 Products Offered
Table 23.Transforming GrowthFactor Beta 1 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. GlobalTransforming GrowthFactor Beta 1 Sales by Geographic Region (2020-2025) & (K Units)
Table 27. GlobalTransforming GrowthFactor Beta 1 Sales Market Share Geographic Region (2020-2025)
Table 28. GlobalTransforming GrowthFactor Beta 1 Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. GlobalTransforming GrowthFactor Beta 1 Revenue Market Share by Geographic Region (2020-2025)
Table 30. GlobalTransforming GrowthFactor Beta 1 Sales by Country/Region (2020-2025) & (K Units)
Table 31. GlobalTransforming GrowthFactor Beta 1 Sales Market Share by Country/Region (2020-2025)
Table 32. GlobalTransforming GrowthFactor Beta 1 Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. GlobalTransforming GrowthFactor Beta 1 Revenue Market Share by Country/Region (2020-2025)
Table 34. AmericasTransforming GrowthFactor Beta 1 Sales by Country (2020-2025) & (K Units)
Table 35. AmericasTransforming GrowthFactor Beta 1 Sales Market Share by Country (2020-2025)
Table 36. AmericasTransforming GrowthFactor Beta 1 Revenue by Country (2020-2025) & ($ millions)
Table 37. AmericasTransforming GrowthFactor Beta 1 Sales byType (2020-2025) & (K Units)
Table 38. AmericasTransforming GrowthFactor Beta 1 Sales by Application (2020-2025) & (K Units)
Table 39. APACTransforming GrowthFactor Beta 1 Sales by Region (2020-2025) & (K Units)
Table 40. APACTransforming GrowthFactor Beta 1 Sales Market Share by Region (2020-2025)
Table 41. APACTransforming GrowthFactor Beta 1 Revenue by Region (2020-2025) & ($ millions)
Table 42. APACTransforming GrowthFactor Beta 1 Sales byType (2020-2025) & (K Units)
Table 43. APACTransforming GrowthFactor Beta 1 Sales by Application (2020-2025) & (K Units)
Table 44. EuropeTransforming GrowthFactor Beta 1 Sales by Country (2020-2025) & (K Units)
Table 45. EuropeTransforming GrowthFactor Beta 1 Revenue by Country (2020-2025) & ($ millions)
Table 46. EuropeTransforming GrowthFactor Beta 1 Sales byType (2020-2025) & (K Units)
Table 47. EuropeTransforming GrowthFactor Beta 1 Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & AfricaTransforming GrowthFactor Beta 1 Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & AfricaTransforming GrowthFactor Beta 1 Revenue Market Share by Country (2020-2025)
Table 50. Middle East & AfricaTransforming GrowthFactor Beta 1 Sales byType (2020-2025) & (K Units)
Table 51. Middle East & AfricaTransforming GrowthFactor Beta 1 Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities ofTransforming GrowthFactor Beta 1
Table 53. Key Market Challenges & Risks ofTransforming GrowthFactor Beta 1
Table 54. Key IndustryTrends ofTransforming GrowthFactor Beta 1
Table 55.Transforming GrowthFactor Beta 1 Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57.Transforming GrowthFactor Beta 1 Distributors List
Table 58.Transforming GrowthFactor Beta 1 Customer List
Table 59. GlobalTransforming GrowthFactor Beta 1 SalesForecast by Region (2026-2031) & (K Units)
Table 60. GlobalTransforming GrowthFactor Beta 1 RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. AmericasTransforming GrowthFactor Beta 1 SalesForecast by Country (2026-2031) & (K Units)
Table 62. AmericasTransforming GrowthFactor Beta 1 Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APACTransforming GrowthFactor Beta 1 SalesForecast by Region (2026-2031) & (K Units)
Table 64. APACTransforming GrowthFactor Beta 1 Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. EuropeTransforming GrowthFactor Beta 1 SalesForecast by Country (2026-2031) & (K Units)
Table 66. EuropeTransforming GrowthFactor Beta 1 RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & AfricaTransforming GrowthFactor Beta 1 SalesForecast by Country (2026-2031) & (K Units)
Table 68. Middle East & AfricaTransforming GrowthFactor Beta 1 RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. GlobalTransforming GrowthFactor Beta 1 SalesForecast byType (2026-2031) & (K Units)
Table 70. GlobalTransforming GrowthFactor Beta 1 RevenueForecast byType (2026-2031) & ($ millions)
Table 71. GlobalTransforming GrowthFactor Beta 1 SalesForecast by Application (2026-2031) & (K Units)
Table 72. GlobalTransforming GrowthFactor Beta 1 RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Roche Basic Information,Transforming GrowthFactor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 74. RocheTransforming GrowthFactor Beta 1 Product Portfolios and Specifications
Table 75. RocheTransforming GrowthFactor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Roche Main Business
Table 77. Roche Latest Developments
Table 78. Shionogi Ltd Basic Information,Transforming GrowthFactor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 79. Shionogi LtdTransforming GrowthFactor Beta 1 Product Portfolios and Specifications
Table 80. Shionogi LtdTransforming GrowthFactor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Shionogi Ltd Main Business
Table 82. Shionogi Ltd Latest Developments
Table 83. Acceleron Pharma Inc Basic Information,Transforming GrowthFactor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 84. Acceleron Pharma IncTransforming GrowthFactor Beta 1 Product Portfolios and Specifications
Table 85. Acceleron Pharma IncTransforming GrowthFactor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Acceleron Pharma Inc Main Business
Table 87. Acceleron Pharma Inc Latest Developments
Table 88. Genzyme Corp Basic Information,Transforming GrowthFactor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 89. Genzyme CorpTransforming GrowthFactor Beta 1 Product Portfolios and Specifications
Table 90. Genzyme CorpTransforming GrowthFactor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Genzyme Corp Main Business
Table 92. Genzyme Corp Latest Developments
Table 93. IsarnaTherapeutics GmbH Basic Information,Transforming GrowthFactor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 94. IsarnaTherapeutics GmbHTransforming GrowthFactor Beta 1 Product Portfolios and Specifications
Table 95. IsarnaTherapeutics GmbHTransforming GrowthFactor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. IsarnaTherapeutics GmbH Main Business
Table 97. IsarnaTherapeutics GmbH Latest Developments
Table 98. Scholar Rock Basic Information,Transforming GrowthFactor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 99. Scholar RockTransforming GrowthFactor Beta 1 Product Portfolios and Specifications
Table 100. Scholar RockTransforming GrowthFactor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Scholar Rock Main Business
Table 102. Scholar Rock Latest Developments
Table 103. Sirnaomics Inc Basic Information,Transforming GrowthFactor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 104. Sirnaomics IncTransforming GrowthFactor Beta 1 Product Portfolios and Specifications
Table 105. Sirnaomics IncTransforming GrowthFactor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Sirnaomics Inc Main Business
Table 107. Sirnaomics Inc Latest Developments
Table 108. Eli Lilly and Co Basic Information,Transforming GrowthFactor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 109. Eli Lilly and CoTransforming GrowthFactor Beta 1 Product Portfolios and Specifications
Table 110. Eli Lilly and CoTransforming GrowthFactor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Eli Lilly and Co Main Business
Table 112. Eli Lilly and Co Latest Developments
Table 113.Formation Biologics Inc Basic Information,Transforming GrowthFactor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 114.Formation Biologics IncTransforming GrowthFactor Beta 1 Product Portfolios and Specifications
Table 115.Formation Biologics IncTransforming GrowthFactor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116.Formation Biologics Inc Main Business
Table 117.Formation Biologics Inc Latest Developments
Table 118. Novartis AG Basic Information,Transforming GrowthFactor Beta 1 Manufacturing Base, Sales Area and Its Competitors
Table 119. Novartis AGTransforming GrowthFactor Beta 1 Product Portfolios and Specifications
Table 120. Novartis AGTransforming GrowthFactor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Novartis AG Main Business
Table 122. Novartis AG Latest Developments
LIST OFFIGURES
Figure 1. Picture ofTransforming GrowthFactor Beta 1
Figure 2.Transforming GrowthFactor Beta 1 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. GlobalTransforming GrowthFactor Beta 1 Sales Growth Rate 2020-2031 (K Units)
Figure 7. GlobalTransforming GrowthFactor Beta 1 Revenue Growth Rate 2020-2031 ($ millions)
Figure 8.Transforming GrowthFactor Beta 1 Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9.Transforming GrowthFactor Beta 1 Sales Market Share by Country/Region (2024)
Figure 10.Transforming GrowthFactor Beta 1 Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Pirfenidone
Figure 12. Product Picture of Galunisertib
Figure 13. Product Picture of Others
Figure 14. GlobalTransforming GrowthFactor Beta 1 Sales Market Share byType in 2025
Figure 15. GlobalTransforming GrowthFactor Beta 1 Revenue Market Share byType (2020-2025)
Figure 16.Transforming GrowthFactor Beta 1 Consumed in IPF
Figure 17. GlobalTransforming GrowthFactor Beta 1 Market: IPF (2020-2025) & (K Units)
Figure 18.Transforming GrowthFactor Beta 1 Consumed in Cancer
Figure 19. GlobalTransforming GrowthFactor Beta 1 Market: Cancer (2020-2025) & (K Units)
Figure 20.Transforming GrowthFactor Beta 1 Consumed in Others
Figure 21. GlobalTransforming GrowthFactor Beta 1 Market: Others (2020-2025) & (K Units)
Figure 22. GlobalTransforming GrowthFactor Beta 1 Sale Market Share by Application (2024)
Figure 23. GlobalTransforming GrowthFactor Beta 1 Revenue Market Share by Application in 2025
Figure 24.Transforming GrowthFactor Beta 1 Sales by Company in 2025 (K Units)
Figure 25. GlobalTransforming GrowthFactor Beta 1 Sales Market Share by Company in 2025
Figure 26.Transforming GrowthFactor Beta 1 Revenue by Company in 2025 ($ millions)
Figure 27. GlobalTransforming GrowthFactor Beta 1 Revenue Market Share by Company in 2025
Figure 28. GlobalTransforming GrowthFactor Beta 1 Sales Market Share by Geographic Region (2020-2025)
Figure 29. GlobalTransforming GrowthFactor Beta 1 Revenue Market Share by Geographic Region in 2025
Figure 30. AmericasTransforming GrowthFactor Beta 1 Sales 2020-2025 (K Units)
Figure 31. AmericasTransforming GrowthFactor Beta 1 Revenue 2020-2025 ($ millions)
Figure 32. APACTransforming GrowthFactor Beta 1 Sales 2020-2025 (K Units)
Figure 33. APACTransforming GrowthFactor Beta 1 Revenue 2020-2025 ($ millions)
Figure 34. EuropeTransforming GrowthFactor Beta 1 Sales 2020-2025 (K Units)
Figure 35. EuropeTransforming GrowthFactor Beta 1 Revenue 2020-2025 ($ millions)
Figure 36. Middle East & AfricaTransforming GrowthFactor Beta 1 Sales 2020-2025 (K Units)
Figure 37. Middle East & AfricaTransforming GrowthFactor Beta 1 Revenue 2020-2025 ($ millions)
Figure 38. AmericasTransforming GrowthFactor Beta 1 Sales Market Share by Country in 2025
Figure 39. AmericasTransforming GrowthFactor Beta 1 Revenue Market Share by Country (2020-2025)
Figure 40. AmericasTransforming GrowthFactor Beta 1 Sales Market Share byType (2020-2025)
Figure 41. AmericasTransforming GrowthFactor Beta 1 Sales Market Share by Application (2020-2025)
Figure 42. United StatesTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 43. CanadaTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 44. MexicoTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 45. BrazilTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 46. APACTransforming GrowthFactor Beta 1 Sales Market Share by Region in 2025
Figure 47. APACTransforming GrowthFactor Beta 1 Revenue Market Share by Region (2020-2025)
Figure 48. APACTransforming GrowthFactor Beta 1 Sales Market Share byType (2020-2025)
Figure 49. APACTransforming GrowthFactor Beta 1 Sales Market Share by Application (2020-2025)
Figure 50. ChinaTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 51. JapanTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 52. South KoreaTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast AsiaTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 54. IndiaTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 55. AustraliaTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwanTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 57. EuropeTransforming GrowthFactor Beta 1 Sales Market Share by Country in 2025
Figure 58. EuropeTransforming GrowthFactor Beta 1 Revenue Market Share by Country (2020-2025)
Figure 59. EuropeTransforming GrowthFactor Beta 1 Sales Market Share byType (2020-2025)
Figure 60. EuropeTransforming GrowthFactor Beta 1 Sales Market Share by Application (2020-2025)
Figure 61. GermanyTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 62.FranceTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 63. UKTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 64. ItalyTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 65. RussiaTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & AfricaTransforming GrowthFactor Beta 1 Sales Market Share by Country (2020-2025)
Figure 67. Middle East & AfricaTransforming GrowthFactor Beta 1 Sales Market Share byType (2020-2025)
Figure 68. Middle East & AfricaTransforming GrowthFactor Beta 1 Sales Market Share by Application (2020-2025)
Figure 69. EgyptTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 70. South AfricaTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 71. IsraelTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 72.TurkeyTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC CountriesTransforming GrowthFactor Beta 1 Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis ofTransforming GrowthFactor Beta 1 in 2025
Figure 75. Manufacturing Process Analysis ofTransforming GrowthFactor Beta 1
Figure 76. Industry Chain Structure ofTransforming GrowthFactor Beta 1
Figure 77. Channels of Distribution
Figure 78. GlobalTransforming GrowthFactor Beta 1 Sales MarketForecast by Region (2026-2031)
Figure 79. GlobalTransforming GrowthFactor Beta 1 Revenue Market ShareForecast by Region (2026-2031)
Figure 80. GlobalTransforming GrowthFactor Beta 1 Sales Market ShareForecast byType (2026-2031)
Figure 81. GlobalTransforming GrowthFactor Beta 1 Revenue Market ShareForecast byType (2026-2031)
Figure 82. GlobalTransforming GrowthFactor Beta 1 Sales Market ShareForecast by Application (2026-2031)
Figure 83. GlobalTransforming GrowthFactor Beta 1 Revenue Market ShareForecast by Application (2026-2031)
